Clinical Drug Development Consultant
Edit Page
Report
Scan day: 12 February 2014 UTC
9
Virus safety - good
Description: Doug Berger, M.D., Ph.D. is a bilingual, American physician consultant, based in Japan, with significant experience in clinical study design and drug development.
Pharmaceutical Consultant in Japan and China: Clinical Drug Development, R&D, and Pharmaceutical Business & Drug Licensing Consulting for pharmaceuticals in Japan and China. Medical Monitor China, Japan and Asia. China and Japan Pharmaceutical Regulatory Guidelines, Market Analysis, ICH, GCP, Biotechnology Partnering, licensing and Business Strategy Specialists, Pharma Consultant in China and Japan. Doug Berger, M.D., Ph.D. & Associates, Pharmaceutical Specialists in China and Japan.
Size: 512 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
Page title: | Pharmaceutical Consultant in Japan and China: Clinical Drug Development, R&D, and Pharmaceutical Business & Drug Licensing Consulting for pharmaceuticals in Japan and China. Medical Monitor China, Japan and Asia. China and Japan Pharmaceutical Regulatory Guidelines, Market Analysis, ICH, GCP, Biotechnology Partnering, licensing and Business Strategy Specialists, Pharma Consultant in China and Japan. Doug Berger, M.D., Ph.D. & Associates, Pharmaceutical Specialists in China and Japan. |
Keywords: | pharmaceutical consulting China and Japan, licensing, drug, clinical trials, Tokyo, Japan, drug, development, pharmaceutical, Tokyo, Japan, drug, development, clinical trials, pharmaceutical, Tokyo, Japan, drug, development, pharmaceutical, Tokyo, Japan, Regulatory Guidelines Japan, drug, development, pharmaceutical, Tokyo, Japan |
Description: | PHARMACEUTICAL DRUG RESEARCH AND DEVELOPMENT IN JAPAN, English, Japanese |
IP-address: | 219.105.32.102 |
WHOIS Info
NS | Name Server: NS01.CHOICENET.NE.JP Name Server: NS03.CHOICENET.NE.JP Name Server: NS04.CHOICENET.NE.JP |
WHOIS | Status: clientTransferProhibited |
Date | Creation Date: 16-jan-2000 Expiration Date: 16-jan-2019 |